Compounds > triazoles
Page last updated: 2024-08-24

triazoles and EBV Infections

triazoles has been researched along with EBV Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busson, P; Guo, X; Ke, L; Khabir, A; Kieff, E; Ling, Y; Tsao, GS; Wang, C; Xiang, Y; Xiong, G; Zeng, M; Zeng, Y; Zhao, B; Zhou, H1
He, A; Miranda, JL1
Feng, L; Feng, QS; He, GP; Li, N; Lin, YX; Liu, LR; Qi, XK; Xie, X; Yang, L; Zeng, YX1
Ali, MA; Chavez, M; Cohen, JI; Dowdell, K; El-Hariry, I; Lee, MJ; Proia, DA; Shatzer, A; Tomita, Y; Trepel, JB1

Other Studies

4 other study(ies) available for triazoles and EBV Infections

ArticleYear
Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 09-05, Volume: 114, Issue:36

    Topics: Adolescent; Adult; Aged; Animals; Azepines; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Enhancer Elements, Genetic; Epigenesis, Genetic; Epstein-Barr Virus Infections; ETS Translocation Variant 6 Protein; Female; Genome, Viral; Heterografts; High-Throughput Nucleotide Sequencing; Histone Code; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nuclear Proteins; Prognosis; Proto-Oncogene Proteins c-ets; Repressor Proteins; Transcription Factors; Triazoles; Young Adult

2017
JQ1 reduces Epstein-Barr virus-associated lymphoproliferative disease in mice without sustained oncogene repression.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:5

    Topics: Animals; Azepines; Epstein-Barr Virus Infections; Gene Expression Regulation, Neoplastic; Herpesvirus 4, Human; Lymphoproliferative Disorders; Mice; Oncogenes; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018
BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc.
    Cell death & disease, 2018, 07-09, Volume: 9, Issue:7

    Topics: Animals; Azepines; Cell Cycle; Cell Line, Tumor; Cell Survival; Epstein-Barr Virus Infections; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proteins; Proto-Oncogene Proteins c-myc; Triazoles

2018
Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood.
    Leukemia & lymphoma, 2017, Volume: 58, Issue:4

    Topics: Animals; B-Lymphocytes; Cell Line, Transformed; Cell Survival; Cells, Cultured; Disease Models, Animal; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Female; Herpesvirus 4, Human; HSC70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Lymphocyte Count; Mice; Mice, SCID; T-Lymphocytes; Triazoles

2017